KCT0004869招募中未知
The effect of SGLT2 inhibitors on cardiac uptake of [18F]FDG in diabetes patients with lymphoma or multiple myeloma: A prospective observational study
lsan Univeristy Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Patient is being treated with SGLT2 inhibitor for type 2 diabetes
- •2. Patient has been diagnosed with lymphoma or multiple myeloma by a hemato-oncologist
- •3. Patient is scheduled to undergo [18F]FDG PET/CT exam
排除标准
- •1. Patient has atrial fibrillation or history of cardiovascular event within the last 6 months
- •2. Patient is using insulin or has a history of using insulin
- •3. Uncontrolled hypertension (>160/110)
- •4. Pregnancy
研究者
相似试验
尚未招募
不适用
The impact of the SGLT2 inhibitor on cardiovascular risk factors in patients with type 2 diabetes, an explanatory randomized trialType 2 diabetesJPRN-UMIN000021669Tokyo Medical University60
招募中
Unknown
To study the effect of a medication(SGLT 2 inhibitor) on the structural changes in the heart in patients with poor heart pumping and irregular heart rhythmCTRI/2023/08/056196Kasturba Medical College
进行中（未招募）
1 期
Effects of SGLT-2 inhibitor on heart function and metabolism in patients with Type 2 diabetes and high risk of heart disease cardiovascular: The SIMPle Randomized Clinical TrialType 2 diabetes and cardiovascular riskEUCTR2016-003743-10-DKHerlev og Gentofte Hospital92
尚未招募
不适用
The effect of SGLT2 inhibitor on diabetic cardiac autonomic neuropathydiabetes mellitusJPRN-UMIN000033541Sakakibara Heart Institute200
已完成
不适用
Study of the safety of SGLT-2 inhibitors for heart failure patients with type 2 diabetes mellitusheart failure patients with type 2 diabetes mellitusJPRN-UMIN000018996ippon Medical School Department of Cardiovascular Medicine20